Apatinib as second-line or later therapy in patients with advanced hepatocellular carcinoma (AHELP): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
乔垣结衣
4小时前
24
50
已完结
1. 当前求助状态已完结, 请及时下载应助文件
2. 系统将在 2025-05-13 11:44:47 删除文件
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI:
文献链接:
其他信息:
出版社: Elsevier BV
作者: Shukui Qin; Qiu Li; Shanzhi Gu; Xiaoming Chen; Lizhu Lin; Zishu Wang; Aibing Xu; Xi Chen; Cuncai Zhou; Zhenggang Ren; Lin Yang; Li Xu; Yuxian Bai; Lei Chen; Jun Li; Hongming Pan; Bangwei Cao; Weijia Fang; Wei Wu; Ge Wang; Ying Cheng; Zhuang Yu; Xu Zhu; Da Jiang; Yinying Lu; Huaming Wang; Jianming Xu; Li Bai; Yunpeng Liu; Hailan Lin; Changping Wu; Yang Zhang; Ping Yan; Chunlei Jin; Jianjun Zou
